Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02290223 · ClinicalTrials.gov registry record · NA
Patient Activation to Address Chronic Pain and Opioid Management in Primary Care
A NA study, sponsored by Kaiser Permanente.
- Completed
- Registry status
- NA
- Development phase
- 376
- Enrollment target
NCT02290223: Completed NA study, sponsored by Kaiser Permanente.
NCT02290223 is a NA study that has completed, run by Kaiser Permanente. The registered enrollment target is 376 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (73% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02290223, a NA study, has completed, sponsored by Kaiser Permanente.
- COMPLETED
- Registry status
- NA
- Development phase
- 376 participants
- Enrollment target
Study Summary
Will a primary care-based behavioral intervention for patient activation and engagement and self-management, for patients with chronic pain who are taking opioid pain medication, result in better patient outcomes than Usual Care?
Primary Outcome
The Patient Activation Measure (PAM) is a 13-item instrument for measuring patient beliefs, knowledge and confidence for engaging in a wide range of health behaviors.Each item is rated 1-4 (strongly disagree =1 to strongly agree=4) and a total raw score is generated (0-52). Raw scores are converted to activation scores using a published conversion table. PAM scores are reported on a 1-100 scale, with higher scores associated with positive health outcomes such as participation in health care and
Interventions
- BEHAVIORAL Behavioral Based Treatment Model
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 376 participants |
| Start Date | 2015-06 |
| Est. Completion | 2017-09-06 |
| Phase | NA |
What the finished NCT02290223 record still lists
NCT02290223 is an interventional study that assigns participants to a tested intervention. The registered 376 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (73% lower).
The record links to 0 conditions, and to 1 intervention - of which Behavioral Based Treatment Model is the first listed.
NCT02290223 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02290223 about?
NCT02290223 is a clinical study titled "Patient Activation to Address Chronic Pain and Opioid Management in Primary Care". Will a primary care-based behavioral intervention for patient activation and engagement and self-management, for patients with chronic pain who are taking opioid pain medication, result in better patient outcomes than Usual Care?
What is the current status of trial NCT02290223?
This trial is currently completed. It is a NA study. The enrollment target is 376 participants. The study started on 2015-06. Estimated completion is 2017-09-06.
What interventions are being tested in trial NCT02290223?
The interventions under investigation include: Behavioral Based Treatment Model (BEHAVIORAL).
Who is sponsoring clinical trial NCT02290223?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02290223's enrollment target sits among peer trials
376 274th of 2000 higher than 1,725 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03102125 · 376 participants · Phase 4
Allograft Dysfunction in Heart Transplant
- NCT05055297 · 376 participants · NA
SELUTION4BTK Trial
- NCT05912647 · 376 participants · NA
Enhancing Diabetes Management Approaches for Patients With Uncontrolled Diabetes
- NCT05963971 · 376 participants · NA
A Bilingual Virtually-based Intervention (PEDALL) for the Prevention of Weight Gain in Childhood ALL Patients Considering Key Genetic and Sociodemographic Risk Factors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia